# A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)

> **NCT01258803** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 92 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Formoterol Fumarate DPI
- **DRUG:** Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer
- **DRUG:** Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) with spacer
- **DRUG:** Placebo MDI with spacer
- **DRUG:** Placebo MDI without spacer
- **DRUG:** Mometasone Furoate DPI

## Key facts

- **NCT ID:** NCT01258803
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258803, "A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01258803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*